Insider Transactions Reported by 17 Insiders of CHIMERIX INC

Location
Durham, NC

Quick Takeaways

  • CHIMERIX INC has 17 insiders with reported activity on this page.
  • No net insider buy/sell flow is currently reported for the last year.
  • Recent transaction rows are not currently available.

What Changed

  • No meaningful buy/sell imbalance is currently visible in the one-year window.
  • Activity will update as new Forms 3/4/5 are filed.

Why This Matters

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Source Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 08 May 2025.

Buys

$0

Shares: 0

Insiders: 0

Sells

$0

Shares: 0

Insiders: 0

Net

$0

Shares: 0

Insiders: 0

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

CHIMERIX INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
CANTEX PHARMACEUTICALS, INC. 10%+ Owner $3,343,550 Mixed 14 Sep 2021
Andriole Michael T. PRESIDENT AND CEO, Director $0 Mixed 21 Apr 2025
Michael Albert Alrutz Svp And General Counsel $0 Mixed 21 Apr 2025
Michelle LaSpaluto Chief Financial Officer $0 Mixed 21 Apr 2025
Allen S. Melemed Chief Medical Officer $0 Mixed 21 Apr 2025
Fred A. Middleton Director $0 Mixed 21 Apr 2025
Robert J. Meyer Director $0 Mixed 21 Apr 2025
Michael A. Sherman Chief Executive Officer, Director $0 Mixed 21 Apr 2025
Martha J. Demski Director $0 Mixed 21 Apr 2025
Thomas J. Riga COO and CCO $0 Mixed 21 Apr 2025
David Jakeman Vp Of Finance And Accounting $0 Mixed 21 Apr 2025
Marc D. Kozin Director Mixed 21 Apr 2025
Pratik S. Multani Director Mixed 21 Apr 2025
Lisa Lynn Decker Director Mixed 21 Apr 2025
Catherine Gilliss Director Mixed 09 Jun 2023
Patrick Machado Director Mixed 09 Jun 2023
Victoria Vakiener Director Mixed 21 Apr 2025

Top shareholders of CHIMERIX INC (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
GLAZER CAPITAL, LLC
13D/G
4.9%
4,614,238
$39,405,593 $0 10 Apr 2025
CANTEX PHARMACEUTICALS, INC.
3/4/5
10%+ Owner
class O/S missing
3,500,000
$3,343,550 14 Sep 2021
Andriole Michael T.
3/4/5
PRESIDENT AND CEO, Director
class O/S missing
900,000
21 Apr 2025
Thomas J. Riga
3/4/5
COO and CCO
class O/S missing
325,000
21 Apr 2025
Allen S. Melemed
3/4/5
CHIEF MEDICAL OFFICER
class O/S missing
275,000
21 Apr 2025
Michael Albert Alrutz
3/4/5
SVP AND GENERAL COUNSEL
class O/S missing
250,000
21 Apr 2025
Michelle LaSpaluto
3/4/5
CHIEF FINANCIAL OFFICER
class O/S missing
250,000
21 Apr 2025
David Jakeman
3/4/5
VP OF FINANCE AND ACCOUNTING
class O/S missing
65,000
21 Apr 2025
Catherine Gilliss
3/4/5
Director
class O/S missing
60,000
09 Jun 2023
Patrick Machado
3/4/5
Director
class O/S missing
60,000
09 Jun 2023

Recent Insider Transactions by Companies or Individuals for CHIMERIX INC

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .